RxDoctor Payments Data

David Cashen, MD

Orthopaedic Surgery · Bradenton, FLNPI 1124035696

Payments from drug & device makers

$130,080in general payments, 2019–2025

Across 81 payments — averaging $1605.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$77K
  • UOC USA Inc$38K
  • Maxx Orthopedics, Inc.$9K
  • Medical Device Business Services, Inc.$3K
  • Smith+Nephew$2K
  • Stryker$1K
  • plus $739 from 15 others
$6,850in research payments, 2019–2025

Across 3 payments — averaging $2283.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$7K

What the payments were for

  • Consulting fees$46,22593%
  • Travel & lodging$1,0802%
  • Food & beverage$2,6165%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$130,080 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$577,036
Medicare patients
990
Services billed
5,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib127$3,425
Ondansetron OdtOndansetron237$1,248
Mupirocin170$928
Diclofenac Sodium14$799
Cefadroxil79$610
Amoxicillin191$339
Meloxicam88$199
Tramadol Hcl57$189
Methylprednisolone15$66
Oxycodone Hcl14$60
Clindamycin Hcl16$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →